MXPA05009428A - Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas. - Google Patents

Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.

Info

Publication number
MXPA05009428A
MXPA05009428A MXPA05009428A MXPA05009428A MXPA05009428A MX PA05009428 A MXPA05009428 A MX PA05009428A MX PA05009428 A MXPA05009428 A MX PA05009428A MX PA05009428 A MXPA05009428 A MX PA05009428A MX PA05009428 A MXPA05009428 A MX PA05009428A
Authority
MX
Mexico
Prior art keywords
compositions
preventing
conditions
methods
related diseases
Prior art date
Application number
MXPA05009428A
Other languages
English (en)
Inventor
Mcshane James
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of MXPA05009428A publication Critical patent/MXPA05009428A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds

Abstract

La invencion provee composiciones farmaceuticas para prevenir y tratar enfermedades y condiciones relacionadas con endotoxinas asi como metodos para hacer y usar tales composiciones.
MXPA05009428A 2003-03-05 2004-03-05 Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas. MXPA05009428A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45202203P 2003-03-05 2003-03-05
PCT/US2004/006713 WO2004078142A2 (en) 2003-03-05 2004-03-05 Compositions and methods for preventing and treating endotoxin-related diseases and conditions

Publications (1)

Publication Number Publication Date
MXPA05009428A true MXPA05009428A (es) 2005-12-12

Family

ID=32962682

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05009428A MXPA05009428A (es) 2003-03-05 2004-03-05 Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.

Country Status (12)

Country Link
US (1) US20080095786A9 (es)
EP (1) EP1601661A2 (es)
JP (1) JP2006519872A (es)
KR (1) KR20060002795A (es)
CN (1) CN1780824A (es)
AU (1) AU2004218358A1 (es)
BR (1) BRPI0408077A (es)
CA (1) CA2516629A1 (es)
MX (1) MXPA05009428A (es)
NO (1) NO20054346L (es)
RU (1) RU2005130771A (es)
WO (1) WO2004078142A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030130212A1 (en) * 1999-01-14 2003-07-10 Rossignol Daniel P. Administration of an anti-endotoxin drug by intravenous infusion
IL151314A0 (en) 2000-02-18 2003-04-10 Eisai Co Ltd Micelles, methods for their preparation and methods for delivery of micelles to patients
EP2338497A1 (en) * 2001-08-10 2011-06-29 Eisai R&D Management Co., Ltd. Treatment and prevention of heat shock protein-associated diseases and conditions
CA2618439A1 (en) * 2005-08-12 2007-02-22 Astellas Pharma Inc. Technique for stabilization of yw753 reparation
KR101457418B1 (ko) * 2009-10-23 2014-11-04 삼성전자주식회사 계층적 부호화 단위의 크기에 따른 비디오 부호화 방법과 그 장치, 및 비디오 복호화 방법과 그 장치
BR112014024139A8 (pt) * 2012-03-28 2018-01-16 Univ Maryland administração de eritoran ou sais farmaceuticamente aceitáveis do mesmo para tratar infecções de ortomixovírus
CN112930184A (zh) * 2018-12-17 2021-06-08 卫材R&D管理有限公司 包含脂质体的配制品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681824A (en) * 1995-06-05 1997-10-28 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia
US6495532B1 (en) * 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6437006B1 (en) * 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
CA2446356C (en) * 2001-05-09 2012-07-10 The Regents Of The University Of Michigan Use of compositions for treating rosacea

Also Published As

Publication number Publication date
WO2004078142A2 (en) 2004-09-16
NO20054346D0 (no) 2005-09-20
RU2005130771A (ru) 2006-01-27
WO2004078142A3 (en) 2004-12-23
US20060222655A1 (en) 2006-10-05
CN1780824A (zh) 2006-05-31
BRPI0408077A (pt) 2006-02-14
AU2004218358A1 (en) 2004-09-16
US20080095786A9 (en) 2008-04-24
CA2516629A1 (en) 2004-09-16
NO20054346L (no) 2005-11-04
EP1601661A2 (en) 2005-12-07
JP2006519872A (ja) 2006-08-31
KR20060002795A (ko) 2006-01-09

Similar Documents

Publication Publication Date Title
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
IL175512A0 (en) Methods of preparing aripiprazole crystalline forms
RS20060320A (en) Substituted indazole-o-glucosides
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
SG130189A1 (en) Substituted indole-o-glucosides
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
MXPA05014166A (es) Metodos y composiciones para tratar enfermedades relacionadas con amiloide.
UA86042C2 (en) Substituted indazole-o-glucosides
TW200732349A (en) Anti-OX40L antibodies and methods using same
NO20055130L (no) Aminocykloheksyleter-forbindelser og deres anvendelse
WO2005046603A3 (en) Pyridine compounds
UA85559C2 (en) Aminobenzophenone compounds
WO2005085188A3 (en) Compounds and methods for anti-tumor therapy
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
TW200716088A (en) Formulations and methods for treating amyloidosis
WO2003099217A3 (en) Methods of treating bacterial infections and diseases associated therewith
WO2004058153A9 (en) Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476.
ZA200604874B (en) Pharmaceutical compositions
WO2004087073A3 (en) Treatment of demyelinating conditions
TW200510398A (en) Novel compounds
WO2005000208A3 (en) Combination therapy for the treatment of neoplasms
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
WO2004073615A3 (en) Deazaflavin compounds and methods of use thereof
TW200531686A (en) Pharmaceutical compositions
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander

Legal Events

Date Code Title Description
GB Transfer or rights
FA Abandonment or withdrawal